Document is current
Any future updates will be listed below
-
Authors
Eichler, F.
Sevin, Caroline
Barth, M.
Pang, F. http://orcid.org/0000-0002-9572-8779
Howie, K.
Walz, M.
Wilds, A.
Calcagni, C.
Chanson, C.
Campbell, L.
-
Funding
Funding for this research was provided by:
Orchard Therapeutics
- License Information
-
More Information
Article History
Received: 14 April 2022
Accepted: 5 September 2022
First Online: 4 October 2022
Declarations
:
: All participants consented to their anonymized data, including anonymized quotes and pseudonymized and/or aggregated information to be used for this research. Study protocol and all study material were approved by an external Institutional Review Board (provider: Pearl IRB, Indianapolis, IN).
: Not applicable.
: Data presented in this paper was collected as part of a study sponsored and funded by Orchard Therapeutics, Ltd., London, UK and was designed through a collaboration among the sponsor and Magnolia Innovation, LLC, Hoboken, NJ. Data was collected by Magnolia Innovation. Dr. Eichler has previously served on an advisory board for Orchard Therapeutics but has no current conflicts of interest with Orchard nor Magnolia Innovation. Dr. Sevin and Dr. Barth have no current conflicts of interest with Orchard nor Magnolia Innovation. Mr. Pang, Ms. Chanson, and Dr. Campbell are previous or current employees of sponsor, Orchard Therapeutics, Ltd. Mr. Calcagni, Mr. Howie, Mr. Walz, and Ms. Wilds are previous or current employees of Magnolia Innovation, LLC.
